Plump Andrew Stewart
- SEC CIK
- 0001977689
In the past year, 3 open-market sale filings worth $5.34M and no purchases.
Current role at each company
- TAK Takeda Pharmaceutical Co LtdPresident, R&Das of Sep 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.34M
- 3 filings
- Net
- −$5.34M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Plump Andrew Stewart as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 (view filing)9:49 PM ET | Sep 2 | 1 day | Plump Andrew StewartPresident, R&D | SSaleAmerican Depositary Shares | −116.2K | $18.49 | −$2.15M | −44.4%145.5K after | 10b5-1 |
| Aug 21, 2026 (view filing)4:30 PM ET | Aug 19 | 2 days | Plump Andrew StewartPresident, R&D | SSaleAmerican Depositary Shares | −19.7K | $18.49 | −$363.3K | −7.0%261.7K after | 10b5-1 |
| Aug 12, 2026 (view filing)9:50 PM ET | Aug 10 | 2 days | Plump Andrew StewartPresident, R&D | SSaleAmerican Depositary Shares | −165.4K | $17.10 | −$2.83M | −17.7%766.6K after |